Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Net Margin: 2013-2018

Historic Net Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to 2,644.51%.

  • Armata Pharmaceuticals' Net Margin rose 1429451.00% to 2,644.51% in Q4 2018 from the same period last year, while for Dec 2018 it was 2,247.61%, marking a year-over-year increase of 1476587.00%. This contributed to the annual value of 955.06% for FY2024, which is 323236.00% up from last year.
  • Armata Pharmaceuticals' Net Margin amounted to 2,644.51% in Q4 2018, which was up 398.99% from 529.97% recorded in Q3 2018.
  • Over the past 5 years, Armata Pharmaceuticals' Net Margin peaked at 14,070.87% during Q3 2014, and registered a low of -43,181.82% during Q4 2016.
  • Over the past 3 years, Armata Pharmaceuticals' median Net Margin value was -6,165.05% (recorded in 2016), while the average stood at -10,287.37%.
  • Per our database at Business Quant, Armata Pharmaceuticals' Net Margin spiked by 164,870,421bps in 2014 and then plummeted by 4,069,744bps in 2016.
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' Net Margin stood at -984.16% in 2014, then crashed by 150,022bps to -2,484.38% in 2015, then plummeted by 4,069,744bps to -43,181.82% in 2016, then surged by 3,153,182bps to -11,650.00% in 2017, then skyrocketed by 1,429,451bps to 2,644.51% in 2018.
  • Its Net Margin stands at 2,644.51% for Q4 2018, versus 529.97% for Q3 2018 and 3,561.36% for Q2 2018.